Context Therapeutics (CNTX) SEC Filings & 10K Form

$1.87
+0.04 (+2.19%)
(As of 05/10/2024 ET)

Recent Context Therapeutics SEC Filings

DateFilerForm TypeView
05/02/2024
6:37 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:16 PM
Context Therapeutics (Filer)
Form ARS
04/26/2024
3:12 PM
Context Therapeutics (Filer)
Form DEFA14A
04/01/2024
6:32 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
7:01 AM
Context Therapeutics (Issuer)
Lehr Martin A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
7:01 AM
Context Therapeutics (Issuer)
Levit Alex C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
7:04 AM
Context Therapeutics (Issuer)
Minai-Azary Jennifer Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
7:28 AM
Context Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/21/2024
6:36 AM
Context Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/21/2024
6:31 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
6:30 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
3:24 PM
Context Therapeutics (Subject)
Lehr Martin A. (Filed by)
Form SC 13G/A
10/31/2023
8:04 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
7:11 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
7:35 AM
Context Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
3:52 PM
BERMAN RICHARD J (Reporting)
Context Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
3:53 PM
Context Therapeutics (Issuer)
Stacey Jennifer Evans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
3:53 PM
Context Therapeutics (Issuer)
West Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
3:53 PM
Context Therapeutics (Issuer)
Kantoff Philip W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CNTX) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners